LENZ logo

LENZ Therapeutics, Inc. (LENZ) Shareholders Equity

Annual Shareholders Equity:

$204.08M+$153.41M(+302.71%)
December 31, 2024

Summary

  • As of today, LENZ annual stockholders equity is $204.08 million, with the most recent change of +$153.41 million (+302.71%) on December 31, 2024.
  • During the last 3 years, LENZ annual shareholders equity has fallen by -$185.76 million (-47.65%).
  • LENZ annual shareholders equity is now -47.65% below its all-time high of $389.84 million, reached on December 1, 2021.

Performance

LENZ Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLENZbalance sheet metrics

Quarterly Shareholders Equity:

$193.93M-$12.44M(-6.03%)
September 30, 2025

Summary

  • As of today, LENZ quarterly stockholders equity is $193.93 million, with the most recent change of -$12.44 million (-6.03%) on September 30, 2025.
  • Over the past year, LENZ quarterly shareholders equity has dropped by -$21.35 million (-9.92%).
  • LENZ quarterly shareholders equity is now -51.53% below its all-time high of $400.13 million, reached on September 1, 2021.

Performance

LENZ Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLENZbalance sheet metrics

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

LENZ Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+302.7%-9.9%
3Y3 Years-47.6%-38.7%
5Y5 Years+9301.3%-

LENZ Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-47.6%+302.7%-38.7%+282.7%
5Y5-Year-47.6%+2182.5%-51.5%+2078.8%
All-TimeAll-Time-47.6%+2182.5%-51.5%+2078.8%

LENZ Shareholders Equity History

DateAnnualQuarterly
Sep 2025
-
$193.93M(-6.0%)
Jun 2025
-
$206.37M(+7.5%)
Mar 2025
-
$192.01M(-5.9%)
Dec 2024
$204.08M(+302.7%)
$204.08M(-5.2%)
Sep 2024
-
$215.28M(+11.6%)
Jun 2024
-
$192.92M(-2.6%)
Mar 2024
-
$198.17M(+291.0%)
Dec 2023
$50.68M(-82.9%)
$50.68M(-75.2%)
Sep 2023
-
$204.02M(-9.0%)
Jun 2023
-
$224.15M(-18.9%)
Mar 2023
-
$276.22M
DateAnnualQuarterly
Dec 2022
$296.29M(-24.0%)
-
Dec 2022
-
$296.29M(-6.4%)
Sep 2022
-
$316.45M(-6.5%)
Jun 2022
-
$338.46M(-6.3%)
Mar 2022
-
$361.30M(-7.3%)
Dec 2021
$389.84M(+4078.0%)
$389.84M(-2.6%)
Sep 2021
-
$400.13M(+5.5%)
Jun 2021
-
$379.18M(+114.9%)
Mar 2021
-
$176.46M(+1900.6%)
Dec 2020
-$9.80M(-341.8%)
-$9.80M
Dec 2019
-$2.22M
-

FAQ

  • What is LENZ Therapeutics, Inc. annual stockholders equity?
  • What is the all-time high annual shareholders equity for LENZ Therapeutics, Inc.?
  • What is LENZ Therapeutics, Inc. annual shareholders equity year-on-year change?
  • What is LENZ Therapeutics, Inc. quarterly stockholders equity?
  • What is the all-time high quarterly shareholders equity for LENZ Therapeutics, Inc.?
  • What is LENZ Therapeutics, Inc. quarterly shareholders equity year-on-year change?

What is LENZ Therapeutics, Inc. annual stockholders equity?

The current annual shareholders equity of LENZ is $204.08M

What is the all-time high annual shareholders equity for LENZ Therapeutics, Inc.?

LENZ Therapeutics, Inc. all-time high annual stockholders equity is $389.84M

What is LENZ Therapeutics, Inc. annual shareholders equity year-on-year change?

Over the past year, LENZ annual stockholders equity has changed by +$153.41M (+302.71%)

What is LENZ Therapeutics, Inc. quarterly stockholders equity?

The current quarterly shareholders equity of LENZ is $193.93M

What is the all-time high quarterly shareholders equity for LENZ Therapeutics, Inc.?

LENZ Therapeutics, Inc. all-time high quarterly stockholders equity is $400.13M

What is LENZ Therapeutics, Inc. quarterly shareholders equity year-on-year change?

Over the past year, LENZ quarterly stockholders equity has changed by -$21.35M (-9.92%)
On this page